Patents by Inventor Gary Paul COOK

Gary Paul COOK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11234939
    Abstract: The present invention relates to oral solid dosage forms comprising a plasma kallikrein inhibitor, in particular a solid form (Form 1) of the compound of Formula A. Also provided are methods of preparing oral solid dosage forms comprising the compound of Formula A using Form 1 of the compound of Formula A.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: February 1, 2022
    Assignee: KalVista Pharmaceuticals Limited
    Inventors: John Herman Collett, Gary Paul Cook, Jamie Joseph Farrar, Michael John Frodsham, Michael Bryan Roe, Richard Simon Todd, Robert Neil Ward
  • Publication number: 20200345647
    Abstract: The present invention relates to oral solid dosage forms comprising a plasma kallikrein inhibitor, in particular a solid form (Form 1) of the compound of Formula A. Also provided are methods of preparing oral solid dosage forms comprising the compound of Formula A using Form 1 of the compound of Formula A.
    Type: Application
    Filed: November 28, 2018
    Publication date: November 5, 2020
    Inventors: John Herman COLLETT, Gary Paul COOK, Jamie Joseph FARRAR, Michael John FRODSHAM, Michael Bryan ROE, Richard Simon TODD, Robert Neil WARD
  • Patent number: 10478409
    Abstract: The invention relates to aqueous suspension pharmaceutical compositions of poorly water soluble drugs, wherein said drugs are selected from compounds of formula I wherein R1-R9 are defined herein; processes for preparing these compositions and their use in medicine, especially their use in the treatment of ocular diseases.
    Type: Grant
    Filed: September 26, 2017
    Date of Patent: November 19, 2019
    Assignee: Kalvista Pharmaceuticals Limited
    Inventors: Gary Paul Cook, Garry Thomas Gwozdz, Theodore Patrick Laslo
  • Publication number: 20180021271
    Abstract: The invention relates to aqueous suspension pharmaceutical compositions of poorly water soluble drugs, wherein said drugs are selected from compounds of formula I wherein R1-R9 are defined herein; processes for preparing these compositions and their use in medicine, especially their use in the treatment of ocular diseases.
    Type: Application
    Filed: September 26, 2017
    Publication date: January 25, 2018
    Inventors: Gary Paul COOK, Garry Thomas GWOZDZ, Theodore Patrick LASLO
  • Patent number: 9849100
    Abstract: The invention relates to aqueous suspension pharmaceutical compositions of poorly water soluble drugs, wherein said drugs are selected from compounds of formula (I) (Formula (I)), wherein R1-R9 are defined herein; processes for preparing these compositions and their use in medicine, especially their use in the treatment of ocular diseases.
    Type: Grant
    Filed: January 9, 2014
    Date of Patent: December 26, 2017
    Assignee: Kalvista Pharmaceuticals Limited
    Inventors: Gary Paul Cook, Garry Thomas Gwozdz, Theodore Patrick Laslo
  • Publication number: 20150342910
    Abstract: The invention relates to aqueous suspension pharmaceutical compositions of poorly water soluble drugs, wherein said drugs are selected from compounds of formula (I) (Formula (I)), wherein R1-R9 are defined herein; processes for preparing these compositions and their use in medicine, especially their use in the treatment of ocular diseases.
    Type: Application
    Filed: January 9, 2014
    Publication date: December 3, 2015
    Applicant: KalVista Pharmaceuticals Limited
    Inventors: Gary Paul COOK, Garry Thomas GWOZDZ, Theodore Patrick LASLO